{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:26:05Z","timestamp":1760984765191},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T00:00:00Z","timestamp":1359417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s12094-012-0998-5","type":"journal-article","created":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T06:31:02Z","timestamp":1359354662000},"page":"720-724","source":"Crossref","is-referenced-by-count":9,"title":["Beam angle selection for intensity-modulated radiotherapy (IMRT) treatment of unresectable pancreatic cancer: are noncoplanar beam angles necessary?"],"prefix":"10.1007","volume":"15","author":[{"given":"D. S.","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. K.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. J.","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. R.","family":"Cardenes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,29]]},"reference":[{"issue":"3","key":"998_CR1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1200\/JCO.2006.07.5663","volume":"25","author":"F Huguet","year":"2007","unstructured":"Huguet F, Andre T, Hammel P, Artru P, Balosso J, Selle F et al (2007) Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. J Clin Oncol 25(3):326\u2013331","journal-title":"J Clin Oncol"},{"issue":"31","key":"998_CR2","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1200\/JCO.2011.34.8904","volume":"29","author":"PJ Loehrer Sr","year":"2011","unstructured":"Loehrer PJ Sr, Feng Y, Cardenes H, Wagner L, Brell JM, Cella D et al (2011) Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol 29(31):4105\u20134112","journal-title":"J Clin Oncol"},{"issue":"8","key":"998_CR3","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4","volume":"48","author":"CG Moertel","year":"1981","unstructured":"Moertel CG, Frytak S, Hahn RG, O\u2019Connell MJ, Reitemeier RJ, Rubin J et al (1981) Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads\u00a0+\u00a05-fluorouracil), and high dose radiation\u00a0+\u00a05-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer 48(8):1705\u20131710","journal-title":"Cancer"},{"issue":"3","key":"998_CR4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.bjc.6603270","volume":"95","author":"AW Blackstock","year":"2006","unstructured":"Blackstock AW, Mornex F, Partensky C, Descos L, Case LD, Melin SA et al (2006) Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study. Br J Cancer 95(3):260\u2013265","journal-title":"Br J Cancer"},{"issue":"5","key":"998_CR5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/COC.0b013e3181e9c103","volume":"34","author":"HR Cardenes","year":"2011","unstructured":"Cardenes HR, Moore AM, Johnson CS, Yu M, Helft P, Chiorean EG et al (2011) A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier Oncology Group study. Am J Clin Oncol 34(5):460\u2013465","journal-title":"Am J Clin Oncol"},{"issue":"8","key":"998_CR6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archsurg.1985.01390320023003","volume":"120","author":"MH Kalser","year":"1985","unstructured":"Kalser MH, Ellenberg SS (1985) Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120(8):899\u2013903","journal-title":"Arch Surg"},{"issue":"6","key":"998_CR7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00000658-199912000-00006","volume":"230","author":"JH Klinkenbijl","year":"1999","unstructured":"Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH et al (1999) Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230(6):776\u2013782 discussion 82-4","journal-title":"Ann Surg"},{"issue":"5","key":"998_CR8","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1245\/s10434-011-1630-6","volume":"18","author":"WF Regine","year":"2011","unstructured":"Regine WF, Winter KA, Abrams R, Safran H, Hoffman JP, Konski A et al (2011) Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup\/RTOG 9704 phase III trial. Ann Surg Oncol 18(5):1319\u20131326","journal-title":"Ann Surg Oncol"},{"issue":"29","key":"998_CR9","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1200\/JCO.2010.30.3446","volume":"28","author":"JL Laethem Van","year":"2010","unstructured":"Van Laethem JL, Hammel P, Mornex F, Azria D, Van Tienhoven G, Vergauwe P et al (2010) Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012\/FFCD-9203\/GERCOR phase II study. J Clin Oncol 28(29):4450\u20134456","journal-title":"J Clin Oncol"},{"issue":"4","key":"998_CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0958-3947(05)80004-4","volume":"17","author":"JC Chu","year":"1992","unstructured":"Chu JC, Solin LJ, Hwang CC, Kessler H, Hanks GE (1992) Three-dimensional dosimetric comparison of radiation therapy treatment planning of the pancreas. Med Dosim 17(4):199\u2013203","journal-title":"Med Dosim"},{"issue":"4","key":"998_CR11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.meddos.2007.02.010","volume":"32","author":"DM Gearheart","year":"2007","unstructured":"Gearheart DM, Walker P, Collett BS, Modur RS (2007) An improved approach to external beam radiation therapy for intra-abdominal cavity lesions for rural cancer centers. Med Dosim 32(4):271\u2013277","journal-title":"Med Dosim"},{"issue":"3","key":"998_CR12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0360-3016(94)00380-4","volume":"31","author":"PD Higgins","year":"1995","unstructured":"Higgins PD, Sohn JW, Fine RM, Schell MC (1995) Three-dimensional conformal pancreas treatment: comparison of four- to six-field techniques. Int J Radiat Oncol Biol Phys 31(3):605\u2013609","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"998_CR13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1440-1673.2006.01627.x","volume":"50","author":"C Osborne","year":"2006","unstructured":"Osborne C, Bydder SA, Ebert MA, Spry NA (2006) Comparison of non-coplanar and coplanar irradiation techniques to treat cancer of the pancreas. Australas Radiol 50(5):463\u2013467","journal-title":"Australas Radiol"},{"issue":"1","key":"998_CR14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.meddos.2009.11.001","volume":"36","author":"Z Sebestyen","year":"2011","unstructured":"Sebestyen Z, Kovacs P, Gulyban A, Farkas R, Bellyei S, Liposits G et al (2011) Conkiss: conformal kidneys sparing 3D noncoplanar radiotherapy treatment for pancreatic cancer as an alternative to IMRT. Med Dosim 36(1):35\u201340","journal-title":"Med Dosim"},{"issue":"2","key":"998_CR15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijrobp.2003.11.003","volume":"59","author":"MT Milano","year":"2004","unstructured":"Milano MT, Chmura SJ, Garofalo MC, Rash C, Roeske JC, Connell PP et al (2004) Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 59(2):445\u2013453","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"998_CR16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0958-3947(02)00094-8","volume":"27","author":"JC Landry","year":"2002","unstructured":"Landry JC, Yang GY, Ting JY, Staley CA, Torres W, Esiashvili N et al (2002) Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose\u2013volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity. Med Dosim 27(2):121\u2013129","journal-title":"Med Dosim"},{"key":"998_CR17","unstructured":"Abelson JA, Murphy JD, Minn AY, Chung M, Fisher GA, Ford JM, et al (2011) Intensity-modulated radiotherapy for pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys. Epub 2011\/12\/27"},{"issue":"2","key":"998_CR18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijrobp.2003.11.019","volume":"59","author":"E Ben-Josef","year":"2004","unstructured":"Ben-Josef E, Shields AF, Vaishampayan U, Vaitkevicius V, El-Rayes BF, McDermott P et al (2004) Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. Int J Radiat Oncol Biol Phys 59(2):454\u2013459","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"998_CR19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijrobp.2009.10.043","volume":"79","author":"S Yovino","year":"2011","unstructured":"Yovino S, Poppe M, Jabbour S, David V, Garofalo M, Pandya N et al (2011) Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers. Int J Radiat Oncol Biol Phys 79(1):158\u2013162","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"998_CR20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.meddos.2010.07.001","volume":"36","author":"SP Srivastava","year":"2011","unstructured":"Srivastava SP, Das IJ, Kumar A, Johnstone PAS (2011) Dosimetric comparison of manual and beam angle optimization of gantry angles in IMRT. Med Dosim 36(3):313\u2013316","journal-title":"Med Dosim"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0998-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-012-0998-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0998-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:51:34Z","timestamp":1559433094000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-012-0998-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,29]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["998"],"URL":"https:\/\/doi.org\/10.1007\/s12094-012-0998-5","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,29]]}}}